Skip to main content
Clinical Trials/IRCT20100127003217N13
IRCT20100127003217N13RecruitingPhase 3

Evaluation of the therapeutic effects of saffron (Crocus sativus) on clinical and electrodiagnostic symptoms of patients with type 2 diabetes: a double-blind clinical trial

Tabriz University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • Having type 2 diabetes
  • Symptoms of sensory neuropathy such as numbless, burning and pain, muscle weakness, atrophy and balance disorders
  • Age more than 18 years
  • Body mass index (BMI) 18.5–35 kg / m
  • Recent diagnosis (maximum 3 months) of type 2 diabetes
  • Willingness to participate in the study

Exclusion Criteria

  • Having type 1 diabetes
  • Gestational diabetes or other specific types of diabetes
  • Insulin therapy over the past three months
  • Having serious gastrointestinal (GI) diseases including peptic ulcers and gastrointestinal bleeding
  • Having an autoimmune disease
  • Osteoarthritis (due to masking the symptoms of neuropathy)
  • Having a history of inherited neuropathy
  • Chronic uremia
  • Allergy to saffron
  • Use of drugs that affect on the symptoms of neuropathy such as antidepressants and anticonvulsants

Investigators

Similar Trials

Evaluation of the therapeutic effects of... | Clinical Trial